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Abstract
Background
Burkholderia cepacia complex (Bcc) is a group of serious pathogens in cystic fibrosis
patients and causes life threatening infections in immunocompromised patients. Species
within the Bcc are widely distributed within the environment, can survive in the presence of
disinfectants and antiseptics, and are inherently multidrug resistant (MDR).
Methods
Dhaka Medical College Hospital (DMCH) patients with a B. cepacia positive blood culture
between 20 October 2016 to 23rd September 2017 were considered as outbreak cases.
Blood stream infections (BSIs) were detected using BacT/ALERT 3D at DMCH. B. cepacia
was isolated on chromogenic UTI media followed by MALDI-TOF. Minimum inhibitory con-
centration (MIC) of clinically relevant antibiotics was determined by agar dilution. Whole
genome sequencing was performed on an Illumina MiSeq platform. Patients’ demographic
and clinical data were collected. Patients’ clinical history and genomic data of the outbreak
strains were merged to investigate possible outbreaks. Ninety-one B. cepacia genomes
were downloaded from ‘Burkholderia Genome Database’ and the genomic background of
the global strains were compared with our outbreak strains.
Results
Among 236 BSIs, 6.35% (15/236) were B. cepacia. Outbreak cases were confined to the
burn critical care unit and, to a lesser extent, the paediatrics department. There was a con-
tinuum of overlapping cases at DMCH between 23 October 2016 to 30 August 2017. Core
genome SNPs showed that the outbreak strains were confined to a single clade, corre-
sponded to a common clone (ST1578). The strains were shown to be MDR and associated
with a mortality of 31% excluding discharge against medical advice. MIC profiles of the
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strains suggested that antibiotics deployed as empirical therapy were invariably inappropri-
ate. The genetic background of the outbreak strains was very similar; however, a few varia-
tions were found regarding the presence of virulence genes. Compared to global strains
from the Burkholderia Genome Database, the Bangladeshi strains were genetically distinct.
Conclusions
Environmental surveillance is required to investigate the aetiology and mode of transmission
of the B. cepacia outbreak. Systematic management of nosocomial outbreaks, particularly
in resource limited regions, will mitigate transmission and will improve patients’ outcomes.
Author summary
The Governmental health system in Bangladesh is free to the general public but given the
huge burden (4–5 times hospital capacity), the Governmental hospitals are always over-
crowded, and infection control is minimal. Antibiotics are used empirically to manage
infections and invariably offered to all patients admitted. Outbreaks are a regular phe-
nomenon in the public hospitals of Bangladesh which are rarely fully analysed. Herein, we
report a B. cepacia outbreak from a burn unit for a protracted period where the patients
were treated with inappropriate antibiotic therapies. B. cepacia is a Gram-negative bacte-
rium, mostly a lung pathogen in cystic fibrosis patients but can also produce infections in
immunosuppressed patients. The epidemiology and molecular data from the outbreak
strains indicate the need for interventions and improved infection control programs to
manage outbreaks in Bangladeshi hospitals.
Introduction
The genus Burkholderia incorporates Gram negative, catalase-producing, lactose-nonferment-
ing), obligately aerobic bacilli and encompasses the species of the Burkholderia cepacia
complex (Bcc), Burkholderia mallei, B. pseudomallei. and B. gladioli [1]. Bcc is composed of at
least 20 different species, including B. cepacia, B. multivorans and B. cenocepacia [1,2]. Bcc was
first described in mid-1980s, in cystic fibrosis (CF) patients as a cause of ‘Cepacia Syndrome’,
characterized by lung function deterioration, bacteremia and death [3]. The members of Bcc
are widely distributed in the environment, including water, soil, fruits and vegetables and can
survive for prolong periods of time in moist environments, even in the presence of disinfec-
tants and antiseptics. They are capable of colonizing fluids in the hospital such as irrigation
solutions or intravenous fluids and, serve as potential source of nosocomial infections [4,5,6].
Bcc rarely cause diseases in healthy individuals and is mostly regarded as a serious pathogen in
cystic fibrosis patients [7]. The pathogens are inherently multidrug resistant (MDR) and highly
transmissible by direct contact [7–9].
Regardless of geographical location nosocomial outbreaks attributed by Bcc are frequent.
Recent outbreaks of Bcc bacteraemia from India, Germany and USA, have been reported par-
ticularly in the immunocompromised patients [6, 10–12]. Bcc outbreaks are always linked to
hospital environment and/or contaminated medical devices, intravenous fluids or antiseptic
solutions [4–6,10–13]. We describe an outbreak of B. cepacia bacteraemia in burn’s critical
care units of Dhaka Medical College Hospital (DMCH) analysed by whole genome
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sequencing. The population structure and genetic relationship of B. cepacia isolated in this
study were compared with 91 global B. cepacia deposited previously in the ‘Burkholderia
Genome Database’ [14].
Methods
Ethical statement
Ethical consent was given by the Ethical Review Committee (ERC) of Dhaka Medical College
Hospital (DMCH) prior to the start of the study and in accordance with the Helsinki Declara-
tion [Memo no: MEU-DMC/ECC/2017/122] [15]. Required written consent was taken from
all the participants for this study.
Hospital setting and outbreak case definition
We carried out this study between 20 October 2016 and 23rd September 2017 in DMCH which
is the largest public hospital in Bangladesh. A total of 527 blood culture samples received by
the clinical microbiology laboratory were included in this study. Detailed microbiological anal-
ysis of isolates, including Whole Genome Sequencing (WGS), performed at Cardiff University,
were undertaken retrospectively. Patients with a B. cepacia positive blood culture were
included as outbreak cases. Patients’ demographic (name, age, sex, locality and socio-eco-
nomic condition) and clinical data (clinical symptoms or reason for hospitalization, ward, type
of infection, admission date, sample collection date, outcome and antimicrobial therapy) were
collected. Clinical data was collected following positive culture results from the local labora-
tory. Additional clinical follow up information was not available in the current study, except
for outcome (discharge, death, discharge against medical advice {DAMA}). The study outline
is described in Fig 1.
Fig 1. Study flowchart.
https://doi.org/10.1371/journal.pntd.0008200.g001
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Purification and screening of phenotypic resistance to the isolates of
interest
Blood stream infections were detected using BacT/ALERT 3D (bioMerieux, North Carolina,
USA) at DMCH. The isolates were sub-cultured onto chromogenic UTI agar (Liofilchem,
Roseto, Italy) and the species were identified by Matrix-Assisted Laser Desorption/Ionization-
Time of Flight (MALDI-TOF) mass spectrometry (MS) (Bruker Daltonics, Bremen, Ger-
many). Minimum inhibitory concentrations (MIC) to clinically relevant antimicrobials
(amoxicillin-clavulanate, piperacillin-tazobactam, ceftriaxone, ceftazidime, cefotaxime, cefe-
pime, imipenem, meropenem, ciprofloxacin, levofloxacin, amikacin, gentamicin, sulfamethox-
azole-trimethoprim, fosfomycin, tigecycline and colistin) were determined by agar dilution
and interpreted according to Clinical and Laboratory Standards Institute (CLSI) breakpoints
[16]. MIC determination was carried out in triplicate.
Illumina MiSeq sequencing
WGS was performed on the Illumina MiSeq platform (Illumina Inc., San Diego, CA). DNA
libraries were prepared for paired end sequencing (2x301 cycles) using Nextera XT v2. Geno-
mic DNA was extracted from overnight culture using the QIAcube (Qiagen, Hilden, Ger-
many), and resulting gDNA was quantified using the Qubit 3.0 (Thermos Fisher Scientific,
Waltham, USA). Quality control of raw reads included fastqc (v0.11.2) and adaptor trimming
was performed using Trimgalore (v0.4.3). Reads were assembled into contigs using the de
novo assembler SPAdes (v3.9.0) (.fasta) and were aligned to the original fastq reads using Bur-
rows-Wheeler aligner (BWA) (v0.7.15). Any error was corrected using Pilon (v1.2). Assembly
metrics were evaluated using Quast (v2.1). The de novo assembly produced multiple contigs
(145–330), with a mean GC content of 50% and mean coverage 12X, annotated with Prokka
(v1.12). Resistance genes were retrieved from Comprehensive Antibiotic Resistance Database
(CARD) [17]. Mutations in ampD were mapped to ampD (BCAL3430) of B. cenocepacia strain
J2315 which possesses a ceftazidime MIC of 2 μg/ml to evaluate the putative cause of ß-lactam
resistance [14,18]. Virulence factors (VFs) were evaluated by Virulence Factor Database
(VFDB) [19].
Multi locus sequence typing (MLST)
B. cepacia (n = 15) isolated in this study was submitted to pubMLST to assign as sequence
types (STs) based on 7 loci [20]. Global B. cepacia (n = 91) genomes were downloaded from
‘Burkholderia Genome Database’ of which 82 strains could not be matched with previously
described STs [14]. We also submitted the 82 genomes from database to pubMLST [20]. A
minimum spanning phylogenetic tree was constructed with 106 B. cepacia genome using
Ridom SeqSphere+ (Ridom GmbH, Mu¨nster, Germany) based on 7 B. cepacia MLST genes.
Core genome phylogenetic analysis
We mapped single nucleotide polymorphisms (SNPs) of global B. cepacia from database
(n = 91) and our outbreak strains (n = 15) with the first isolated strain in our study, dm93
(used as reference genome) using Snippy (3.2) [21]. SNPs alignemnt was performed to build a
high-resolution phylogeny. We constructed a maximum likelihood (ML) tree using FastTree
(2.1.3). We employed Interactive Tree of Life (iTOL) to visualize the tree [22].
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Investigating possible outbreaks
Data extracted from patients’ clinical history and WGS data of the outbreak strains were evalu-
ated to investigate possible outbreaks. Likely epidemiological links on transmission (patient to
patient connectivity) was predicted if there is overlapping of hospital stay among the outbreak
cases (Fig 2). Detailed epidemiological information and subsequent infection control measures
were not available as the microbiological information was only available retrospectively. Infec-
tion Prevention and Control (IPC) measures were not implemented at the time due to the lim-
ited and untimely microbiological information at the DMCH.
Accession numbers
WGS data of all B. cepacia in this study were deposited in the National Centre for Biotechnol-
ogy Information under accession numbers stated below.
Accession Organism
SNSF00000000 Burkholderia cepacia b219
SNSG00000000 Burkholderia cepacia b212
SNSH00000000 Burkholderia cepacia b163
SNSI00000000 Burkholderia cepacia b124
SNSJ00000000 Burkholderia cepacia b111
SNSK00000000 Burkholderia cepacia b101
SNSL00000000 Burkholderia cepacia b100
SNSM00000000 Burkholderia cepacia b98
SNSN00000000 Burkholderia cepacia b84
SNSO00000000 Burkholderia cepacia b64
SNSP00000000 Burkholderia cepacia b19
SNSQ00000000 Burkholderia cepacia b13
SNSR00000000 Burkholderia cepacia b6
SNSS00000000 Burkholderia cepacia dm93
SSHL00000000 Burkholderia cepacia b99
Results
Study population and overview of B. cepacia cases
Among 527 blood culture specimens, 45% (236/527) were culture positive and 3% (15/527)
were B. cepacia bacteraemia (Fig 1). Of the 15 B. cepacia infected patients, 7 (46.7%) were male
and 8 (53.3%) were female; the mean (±SD) age was 14 years (±12.57). All the patients in this
cohort belonged to a low socio-economic group (lower middle to below the national poverty
level). The mean (±SD) hospital stay of B. cepacia cases was 43.9 days (±27.1). Antibiotic usage
among the cases with B. cepacia septicaemia was: ceftriaxone, 80.0%; amikacin, 53.3%; levo-
floxacin, 33.3%; ceftazidime, 20%; meropenem, 13.3%, colistin, 13.3%; flucloxacillin, 6.7%; azi-
thromycin, 6.7%; gentamicin, 6.7%; clindamycin, 6.7%; cefuroxime, 6.7% (Table 1). Two of the
B. cepacia cases took discharge against medical advice (DAMA). Not including DAMA, the
mortality rate was 31% (4/13) (Fig 2; Table 1). Patient characteristics are illustrated in Table 1.
The first case was admitted to paediatrics department of DMCH on the 23rd of October 2016.
According to hospital records, the patient was a suspected case of sepsis, and blood was sent
for culture and sensitivity on the 2nd of November 2016 which was positive for B. cepacia. The
rest of the cases were confined to the burn HDU or the burn paediatric HDU or the burn ICU
(Fig 2; Table 1). Excluding DAMA (5/135), in the burn unit, the mortality rate for patients
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Fig 2. Length of hospital stay of the patients with B. cepacia bacteraemia.
https://doi.org/10.1371/journal.pntd.0008200.g002
Table 1. Clinical characteristics of patients infected with B. cepacia.
Strain ID Cases Ward Sample Agea Sex SEC DOA DOSC DOD THS Underlying disease Antibiotic history Outcome
dm93 Case 1 Pae Blood 2.5 M BPL 23.10.16 02.11.16 7.11.16 16 Unknownb CRO, GEN Discharge
b19 Case 2 Burn HDU Blood 30 F BPL 25.10.16 22.11.16 21.1.17 58 35% FB CRO DAMA
b06 Case 3 Burn HDU Blood 22 M Poor 10.11.16 22.11.16 30.11.16 21 35% FB CFU, CLN Discharge
b13 Case 4 Burn HDU Blood 45 F BPL 13.11.16 22.11.16 26.11.16 14 25% FB AK, CAZ Died
b64 Case 5 Burn Pae. HDU Blood 3.5 F Poor 14.12.16 02.01.17 2.2.17 51 15% FB AZ, CL, CRO Discharge
b84 Case 6 Burn HDU Blood 15 M BPL 14.01.17 26.01.17 23.3.17 69 40% EB AK, CAZ, MEM Discharge
b98 Case 7 Burn ICU Blood 5 F BPL 04.02.17 09.02.17 10.2.17 7 45% FB with II AK, CRO, FLU Died
b99 Case 8 Burn ICU Blood 10 F LM 03.02.17 09.02.17 09.02.17 7 30% MBc CRO, LEVO DAMA
b100 Case 9 Burn Pae. HDU Blood 2.5 F LM 28.01.17 09.02.17 8.4.17 71 22% SB AK, CRO, LEVO Discharge
b101 Case 10 Burn Pae. HDU Blood 7 M BPL 03.02.17 09.02.17 17.2.17 15 43% FB AK, CRO Died
b111 Case 11 Burn HDU Blood 19 M Poor 16.01.17 23.02.17 7.4.17 82 30% FB AK, CRO, MEM Discharge
b124 Case 12 Burn Pae. HDU Blood 3.5 F BPL 25.02.17 05.03.17 23.4.17 58 30% FB CAZ, CL, CRO Died
b163 Case 13 Burn ICU Blood 1.5 M Poor 10.4.17 17.4.17 26.5.17 46 40% SB CRO, LEVO Discharge
b212 Case 14 Burn HDU Blood 23 F Poor 20.5.17 31.5.17 22.6.17 34 35% FB AK, CRO, LEVO Discharge
b219 Case 15 Burn HDU Blood 20 M Poor 15.6.17 19.6.17 30.8.17 76 35% EB with II AK, CRO, LEVO Discharge
Cases were delineated according to date of isolation of B. cepacia chronologically. ICU, intensive care unit; HDU, high dependency unit, M, male; F, female; SEC, socio-
economic condition; BPL, below poverty level, LM, lower middle; DOA, date of admission; DOSC, date of sample collection; DOD, date of discharge/DAMA/death;
THS, total hospital stay; Pae, paediatrics; FB, flame burn, EB, electric burn; II, inhalation injury; MB, mixed bun; SC, scald burn; DAMA, discharge against medical
advice. AK, amikacin; AZ, azithromycin; CAZ, ceftazidime; CFU, cefuroxime; CL, colistin; CLN, clindamycin; CRO, ceftriaxone; FLU, flucloxacillin; GEN, gentamicin;
LEVO, levofloxacin; MEM, meropenem
aAge are given in years
bUnderlying disease was not available in hospital record; however, this case was clinically suspected as sepsis and therefore, blood was referred for culture
cCombination of chemical and flame burn
https://doi.org/10.1371/journal.pntd.0008200.t001
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with other bacterial sepsis was higher (60.17%, 71/118) compared to B. cepacia sepsis (33.33%,
4/12) (p<0.1).
Clonal relationship with global B. cepacia
B. cepacia isolated in this study were assigned as a single novel ST, ST1578 (Fig 3). All strains
(n = 106) were grouped into 9 clusters (Fig 3). The Bangladeshi strains shared ST clusters with
strains from Australia, USA, South Korea, Thailand, UK and Malaysia. Interestingly, STs dif-
fered according to geographical area (Fig 3). Core genome alignment also suggested that the
Bangladeshi B. cepacia are genetically closer to environmental strains of Australian origin
rather than human strains isolated from cystic fibrosis patients in the UK (LMG16656.fsa nt),
Thailand (LO6.fasta), and other Asian strains (Fig 4).
Outbreak investigation
We documented this outbreak between October 2016 and August 2017 at DMCH (Fig 2). All
outbreak cases had clinical signs of sepsis at the time of sample collection and patients in burn
critical units were undergoing artificial ventilation and had central venous catheter lines and
urinary catheters at the time of diagnosis. There was a continuous overlapping of patients at
DMCH during the outbreak period (Table 1; Fig 2). Core genome SNPs showed that the out-
break strains were confined to a single clade (Fig 4; S1 Data), corresponded to a common
clone (ST1578) (Fig 3).
Background on resistance and virulence
MICs were performed in triplicate and all repetitions were within one-dilution. There are no
MIC breakpoints for B. cepacia recommended by EUCAST [23]. According to CLSI
Fig 3. Minimum spanning tree of B. cepacia by MLST type. Each node within the tree represents a single ST. The
size of the nodes is proportional to the number of isolates represented by corresponding node. Selected nodes are
labelled with corresponding STs, and number of isolates represented. All global strains including Bangladeshi outbreak
strains mentioned in this diagram were assigned as corresponding STs in this study except ST10, ST44, ST807 and
ST810.
https://doi.org/10.1371/journal.pntd.0008200.g003
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breakpoints, 20% of B. cepacia (in this study) were resistant to ceftazidime and 93.33% inter-
mediate resistant to levofloxacin. All the outbreak strains had high MIC value for amoxicillin-
clavulanate, amikacin, gentamicin, fosfomycin, trimethoprim-sulfamethoxazole and colistin
(Table 2). All were sensitive to meropenem (Table 2) [16]. MIC value of relevant antimicrobi-
als are stated in Table 2. According to their MIC profiles, antibiotics deployed as empirical
therapy to treat outbreak cases were invariably deemed to be inappropriate (Table 1). The anti-
microbial resistance genes identified in the outbreak strains were identical (Fig 4; S1 Data).
Likewise, ampD for all strains was homogenous, however, compared to ampD (BCAL3430) of
B. cenocepacia strain J2315, we found 10 substitutions of amino acid in ampD (S1 Fig). The
outbreak strains were shown to possess more resistant genes than other global strains (Fig 4;
S1 Data).
The Bangladeshi outbreak strains shared some common virulence genes with the global
strains (bimA, boaAB, pilABCDNOQRSTV, gmhA, manC, wcbABCDEFGHIJKLMNOPQRST,
wzm/wzt2, cheABDRWYZ, flgABCDEFGHIJKLMN, fliACDEFGHIJKLMNOPQRS, motAB, tsr,
bspI2/bspI3, bspR2/bspR3/bspR4/bspR5, pmlI/bspI1, pmlR/bspR1, bapABC, basJ, bicAP,
bipBCD, bopACE, bprABCDPQ, bsaKLMNOPQRSTUVXYZ, orgAB, spaP, gene for T6SS),
although two of the global strains (MSMB1338WGS.fsa_nt and DWS16B-4.fsa_nt) were nega-
tive for all genes from VFDB (Fig 5; S1 Data). There was variation in the presence of virulence
Fig 4. A maximum likelihood tree of B. cepacia by core genome SNPs with epidemiological data and antimicrobial
resistance genes. Country of origin is represented by specific colour of node. Node level are highlighted according to source
of sample. Global strains are stated with specific codes. Original strain IDs with corresponding codes are compiled with
supplementary data (S1 Data). ARG, antimicrobial resistance genes; U, unknown.
https://doi.org/10.1371/journal.pntd.0008200.g004
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genes between our clinical outbreak strains and previous clinical B. cepacia (LMG16656.fsa nt
and LO6.fasta) isolated from CF patients (Fig 5; S1 Data).
Discussion
Although B. cepacia is considered almost exclusively a pathogen for CF patients [3,7], our
study reported B. cepacia bacteraemia predominantly from burns patients. B. cepacia are con-
sidered opportunistic human pathogens and can be transmitted to patients via environmental
contamination or person-to-person contact [4–6,8,9]. Burns patients are generally more sus-
ceptible to infection due to impaired immune function. Risk factors for sepsis in burns include
>20% of total body surface area (TBSA), inhalation injury, delayed burn wound excision,
increased length of hospital stay, use of artificial medical devices and ICU admission [24–28].
Patients in burn ICUs are more vulnerable to septicaemia than general ICU patients [29]. Our
findings demonstrate an outbreak of bacteraemia in DMCH caused by a single clone of B.
cepacia ST1578, mostly confined to patients admitted in burn critical care units (Fig 2). The
outbreak cases had a mean hospital stay of 43.9 days and straddled each other implying trans-
mission via direct patient contact and/or patient to hospital environment and vice versa. Clini-
cally, this outbreak was associated with a mortality rate of 31% (Fig 2; Table 1).
Previous studies show that burn sepsis accounts for 50–60% of deaths in burn patients
[30,31]. In this study, mortality due to burn sepsis with bacteria other than B. cepacia (60.17%)
was significantly higher than B. cepacia sepsis (33.33%) (p<0.1). A limitation of the current
study was the lacked sufficient clinical information to access and to investigate why the mortal-
ity rate was significantly lower for B. cepacia cases. At the time of enrolment many of these
patients were on “inadequate” antibiotics based on our susceptibility data. However, there are
limitations to the interpretation of AST results for B. cepacia and we lack data on whether anti-
biotics were changed later during hospital stay. It is possible there were other factors favouring
Table 2. MIC value of B. cepacia in this study against relevant antibiotics (n = 15).
Strain ID AUGa Pip-Taza CROa CAZa CTXa CEFa IMPa MEMa CIPa LEVOa AKa GENa Fosa SXT-TRMa Tigea Cla
dm93 >256 4 8 4 16 8 8 4 2 4 64 >256 >256 32 16 >256
b19 >256 8 16 8 32 16 8 4 1 4 256 >256 >256 64 4 >256
b06 >256 8 16 8 32 16 8 4 1 4 256 >256 >256 32 16 >256
b13 >256 8 16 8 32 16 8 4 2 4 256 >256 >256 32 16 >256
b64 >256 2 4 2 8 8 8 2 2 4 64 >256 >256 64 8 >256
b84 >256 8 16 4 16 16 8 4 2 4 256 >256 >256 64 16 >256
b98 >256 2 4 2 8 8 8 2 2 4 64 >256 >256 64 8 >256
b99 >256 16 32 8 32 32 8 4 2 4 256 >256 >256 32 4 >256
b100 >256 8 16 4 32 16 8 4 2 4 256 >256 >256 64 8 >256
b101 >256 2 4 2 8 8 8 2 2 4 64 >256 >256 32 8 >256
b111 >256 2 4 2 8 8 8 2 1 2 256 >256 >256 64 4 >256
b124 >256 2 16 8 16 16 8 4 2 4 256 >256 >256 64 16 >256
b163 >256 16 32 16 32 8 8 4 2 4 128 >256 >256 32 16 >256
b212 >256 8 16 16 16 16 8 4 2 4 128 >256 >256 64 16 >256
b219 >256 16 32 32 32 32 8 4 2 4 64 >256 >256 64 16 >256
aMIC values are indicated by mg/l
MIC values were determined in triplicate. AK, amikacin; AUG, amoxicillin-clavulanate; Pip-Taz, piperacillin-tazobactam; Cl, colistin; CRO, ceftriaxone; CAZ,
ceftazidime; CTX, cefotaxime; CEF, cefepime; Fos, fosfomycin; GEN, gentamicin; IMP, imipenem; MEM, meropenem; CIP, ciprofloxacin; LEVO, levofloxacin;
SXT-TRM, trimethoprim-sulfamethoxazole; Tige, tigecycline
https://doi.org/10.1371/journal.pntd.0008200.t002
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survival in the group infected with B. cepacia, including possibly relatively lower pathogenicity
of B. cepacia as a cause of bacteraemia. B. cepacia has been described as a cause of pseudo-out-
breaks [32]. Although this possibility should be considered here the timing of infections sug-
gest this was not the case, and a persistent environmental source of cross contamination on
the burn unit was a more likely cause. Unsurprisingly, radical infection control programs can
mitigate the spread of infections and improve patient outcomes in burn units [33]. No IPC
intervention was undertaken here because the outbreak was identified retrospectively.
MDR Gram-negative bacteria infections have become a serious challenge in health care set-
tings as a result of both intrinsic and acquired resistance mechanisms, limiting therapeutic
options [8]. B. cepacia is of concern due to their intrinsic resistance to clinically relevant antibi-
otics such as aminoglycosides and polymyxins [34]. In this study, all B. cepacia showed very
high MIC breakpoints to amikacin and gentamicin mediated by resistance genes ant, aph and
aadA2 and/or overexpression of efflux pump such as ArmA, CoeA (Fig 4; S1 Data) [34–36].
Burkholderia spp. are typically resistance to colistin due to a unique intrinsic amino arabinose
biosynthesis operon [33]. Genome sequencing also identified resistance genes such as adeF,
qacH, tetC and sul1 (Fig 4; S1 Data) which contribute to phenotypic resistance of B. cepacia
(Table 2). Mutations in ampD are associated with the upregulation of ß-lactams degrading
enzymes, PenB and AmpC. This mechanism has been found to be one of the causes of ß-lac-
tam resistance in B. cepacia [18,34]. Mutations in ampD were identical in all B. cepacia ana-
lysed in our study and all the isolates had high MIC value for amoxicillin-clavulanate;
however, MICs for piperacillin-tazobactam and cephalosporins were variable (Table 2). Per-
haps enzymatic degradation was mainly responsible for putative ß-lactam resistance in this
study although we did not evaluate the expression of ß-lactamase such as PenB, AmpC or
PenA in relation to AmpD mutations [18,34]. Although the empirical antibiotics were shown
Fig 5. Heatmap showing the presence of virulence genes in B. cepacia. Global strains are stated with specific codes.
Original strain IDs with corresponding codes are compiled with supplementary data (S1 Data). No VF was found in
MSMB1338WGS.fsa_nt and DWS16B-4.fsa_nt. Apart from this two strains, other strains were shown to be positive for
common virulence genes (bimA, boaAB, pilABCDNOQRSTV, gmhA, manC, wcbABCDEFGHIJKLMNOPQRST, wzm/
wzt2, cheABDRWYZ, flgABCDEFGHIJKLMN, fliACDEFGHIJKLMNOPQRS, motAB, tsr, bspI2/bspI3, bspR2/bspR3/
bspR4/bspR5, pmlI/bspI1, pmlR/bspR1, bapABC, basJ, bicAP, bipBCD, bopACE, bprABCDPQ,
bsaKLMNOPQRSTUVXYZ, orgAB, spaP, gene for T6SS). These common VFs were not included in heatmap. Violet
indicates the presence and grey indicates the absence of VF in the respective strain. Virulence genes in operon (orfHM,
aaiAB, vscNR, ureBG, vasAG, farAB, lpxAC, vapA1/vapA, rmlAC, katAG, syrCD, ifgBGH, algCUW, rmlABC, clpB.clpV/
clpV1, adeFGH, pvdAFH, phzB2/D2/E2/F2, hemBCEL, flhABCDFG, pchABCDEFGHIR) are represented by the
intensity of violet—the increase in intensity is proportional to number of genes.
https://doi.org/10.1371/journal.pntd.0008200.g005
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to be ineffective (Table 1), the relationship between patients’ morbidity/mortality and antibiot-
ics prescription cannot be fully explored as datasets are incomplete.
Virulence of B. cepacia is typically related to adhesins, invasins, intracellular pathogenicity,
antiphagocytic factors, secretory and signalling systems [19,37]. A set of virulence genes in
relation to all steps in pathogenesis were identified in Bangladeshi outbreak strains B. cepacia
(Fig 5; S1 Data). However, whether other virulence determinants are associated with the ability
to cause bacteraemia, and the role of patient factors, could not be determined by this current
study.
B. cepacia identified in this study belonged to a novel clonal type ST1578 (Fig 3). The genetic
background of the outbreak strains was very similar; however, a few variations were found
regarding the presence of virulence genes (Fig 5; S1 Data). Compared to global strains from the
database, resistance genes for aminoglycosides (ant(2'')-Ia, aph(6)-Id, aph(3'')-Ib, aadA2), fluo-
roquinolones (qacH), tetracycline (tet(C)) and sulphonamide (sul1) were found only among the
strains isolated in this study (Fig 4; S1 Data). Virulence gene, aai was absent in our outbreak
strain which was common in both human strains, LMG16656.fsa nt and LO6.fasta, (from Bur-
kholderia Genome Database), but the overall virulence pattern of the outbreak strains was most
similar to LMG16656.fsa nt (human strain isolated from the UK) than LO6.fasta (human strain
isolated from Thailand). Compared to B. cepacia LO6.fasta, flagellar protein (lfg, lfh, lfi), secre-
tory system (clpV1, vsc, iagB, spaR), regulatory protein (prrA) were absent in the Bangladeshi
strains (Fig 5; S1 Data). Thus, it can be inferred that the Bangladeshi outbreak strains identified
in this study are genetically distinct from global strains retrieved from the database.
Although we did not fully evaluate the epidemiological link between patients and the envi-
ronment, epidemiological and molecular data suggest that the outbreak clone was circulating
within DMCH over a protracted period (Fig 2). It is disconcerting that antibiotic pressure
might have enhanced the elevation in antibiotic resistance during the outbreak [35,36]. Identi-
fication of environmental sources of the outbreak followed by patient management can reduce
the risk of infections in vulnerable populations [4–6,10–13,29].
Supporting information
S1 Fig. Substitutions of amino acid in ampD compared to ampD (BCAL3430) of B. cenoce-
pacia strain J2315. Substitutions are underlined by red.
(TIF)
S1 Data. Fig 4, Table 2, Fig 5.
(XLSX)
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